Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahmoud Aljurf

Showing results (271-280 of 403) with videos related to

Pageof 41
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 2016
Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group StudyStephen Couban, Mahmoud Aljurf, Sylvie Lachance, et al.
Cancer|January 25, 2017
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysisFotios V Michelis, Vikas Gupta, Mei-Jie Zhang, et al.
Bone Marrow Transplantation|January 30, 2021
Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMTSimone Cesaro, Gloria Tridello, Nina Simone Knelange, et al.
Bone Marrow Transplantation|April 10, 2026
Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMTAlexandros Kanellopoulos, Linda Koster, Hugues de Lavallade, et al.
Blood|March 13, 2012
Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor eraErica Warlick, Kwang Woo Ahn, Tanya L Pedersen, et al.
Bone Marrow Transplantation|March 29, 2022
Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012Cinthya Correa, Oscar Gonzalez-Ramella, Helen Baldomero, et al.
Cytotherapy|May 14, 2026
Real-world outcomes of Axicabtagene Ciloleucel CAR-T therapy in large B-cell lymphoma: a single-center observational studyKhalid Alsuhaibani, Amal Hejab, Maha Aljasser, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 17, 2017
Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic LeukemiaBrian T Hill, Kwang Woo Ahn, Zhen-Huan Hu, et al.
The Lancet. Haematology|July 3, 2025
Allogeneic haematopoietic cell transplantation in peripheral T-cell lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines CommitteeGandhi Damaj, Ali Bazarbachi, Philipp Berning, et al.
Hematology/Oncology and Stem Cell Therapy|October 16, 2024
Special Report: Summary of the eighth workshop of the worldwide network for blood and marrow transplantation on the status and issues related to hematopoietic stem cell transplantation in near-east countries, held in Pakistan from September 22 to 23, 2022Hildegard T Greinix, Raheel Iftikhar, Qamar Un Nisa Chaudhry, et al.
Pageof 41

Showing results (271-280 of 403) with videos related to

Sort By:
Pageof 41
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 2016
Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group StudyStephen Couban, Mahmoud Aljurf, Sylvie Lachance, et al.
Cancer|January 25, 2017
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysisFotios V Michelis, Vikas Gupta, Mei-Jie Zhang, et al.
Bone Marrow Transplantation|January 30, 2021
Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMTSimone Cesaro, Gloria Tridello, Nina Simone Knelange, et al.
Bone Marrow Transplantation|April 10, 2026
Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMTAlexandros Kanellopoulos, Linda Koster, Hugues de Lavallade, et al.
Blood|March 13, 2012
Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor eraErica Warlick, Kwang Woo Ahn, Tanya L Pedersen, et al.
Bone Marrow Transplantation|March 29, 2022
Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012Cinthya Correa, Oscar Gonzalez-Ramella, Helen Baldomero, et al.
Cytotherapy|May 14, 2026
Real-world outcomes of Axicabtagene Ciloleucel CAR-T therapy in large B-cell lymphoma: a single-center observational studyKhalid Alsuhaibani, Amal Hejab, Maha Aljasser, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 17, 2017
Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic LeukemiaBrian T Hill, Kwang Woo Ahn, Zhen-Huan Hu, et al.
The Lancet. Haematology|July 3, 2025
Allogeneic haematopoietic cell transplantation in peripheral T-cell lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines CommitteeGandhi Damaj, Ali Bazarbachi, Philipp Berning, et al.
Hematology/Oncology and Stem Cell Therapy|October 16, 2024
Special Report: Summary of the eighth workshop of the worldwide network for blood and marrow transplantation on the status and issues related to hematopoietic stem cell transplantation in near-east countries, held in Pakistan from September 22 to 23, 2022Hildegard T Greinix, Raheel Iftikhar, Qamar Un Nisa Chaudhry, et al.
Pageof 41